Cognitive performances and DAT imaging in early Parkinson's disease with mild cognitive impairment: a preliminary study(499 views) Pellecchia MT, Picillo M, Santangelo G, Longo K, Moccia M, Erro R, Amboni M, Vitale C, Vicidomini C, Salvatore M, Barone P, Pappata S
Keywords: Spect, Cognition, Dopamine Transporter, Early Parkinson, S Disease, Mild Cognitive Impairment, Ioflupane I 123, Adult, Article, Attention, Clinical Article, Controlled Study, Disease Duration, Disease Severity, Dsm-Iv, Executive Function, Female, Hospital Anxiety And Depression Scale, Human, Learning, Memory, Parkinson Disease, Psychologic Test, Single Photon Emission Computer Tomography, Spect Scanner, Stroop Test, Unified Parkinson Disease Rating Scale, Working Memory, 2-Carbomethoxy-8-(3-Fluoropropyl)-3-(4-Iodophenyl)tropane, Tropane Derivative, Aged, Complication, Corpus Striatum, Diagnostic Use, Metabolism, Middle Aged, Procedures, Psychological Rating Scale, Scintiscanning, Dopamine Plasma Membrane Transport Proteins, Psychiatric Status Rating Scales, Emission-Computed, Single-Photon,
Affiliations: *** IBB - CNR ***
Center for Neurodegenerative Diseases, University of Salerno, Salerno, Italy.
Department of Neurological Sciences, University Federico II, Naples, Italy
Department of Psychology, Neuropsychology Laboratory, Second University of Naples, Caserta, Italy
IDC Hermitage-Capodimonte, Naples, Italy
University Parthenope, Naples, Italy
Institute of Biostructure and Bioimaging, CNR, Naples, Italy
Department of Advanced Biomedical Sciences, University Federico II, Naples, Italy
References: Williams-Gray, C.H., Foltynie, T., Brayne, C.E.G., Evolution of cognitive dysfunction in an incident Parkinson's disease cohort (2007) Brain, 130, pp. 1787-179
Elgh, E., Domellof, M., Linder, J., Cognitive function in early Parkinson's disease: a population-based study (2009) Eur J Neurol, 16, pp. 1278-1284
Muslimovic, D., Post, B., Speelman, J.D., Schmand, B., Cognitive profile of patients with newly diagnosed Parkinson's disease (2005) Neurology, 65, pp. 1239-1245
Aarsland, D., Bronnick, K., Williams-Gray, C., Mild cognitive impairment in Parkinson disease: a multicenter pooled analysis (2010) Neurology, 5, pp. 1062-1069
Pfeiffer, H.C., Løkkegaard, A., Zoetmulder, M., Cognitive impairment in early-stage non-demented Parkinson's disease patients (2014) Acta Neurol Scand, 129, pp. 307-318
Pavese, N., PET studies in Parkinson's disease motor and cognitive dysfunction (2012) Parkinsonism Relat Disord, 18, pp. S96-S99
Pappatà, S., Salvatore, E., Postiglione, A., In vivo imaging of neurotransmission and brain receptors in dementia (2008) J Neuroimaging, 18, pp. 111-124
Fitzpatrick, T., Mattis, P., Eidelberg, D., Functional imaging of cognitive impairment in Parkinson's disease (2010) Clin EEG Neurosci, 41, pp. 119-126
Muller, U., Wachter, T., Barthel, H., Striatal [123I] b-CIT SPECT and prefrontal cognitive functions in Parkinson's disease (2000) J Neural Transm, 107, pp. 303-319
Duchesne, N., Soucy, J.-P., Masson, H., Cognitive deficits and striatal dopaminergic denervation in Parkinson's disease: a single photon emission computed tomography study using 123Iodine-b-CIT in patients ON and OFF levodopa (2002) Clin Neuropharmacol, 25, pp. 216-224
Cropley, V.L., Fujita, M., Bara-Jimenez, W., Pre and post synaptic dopamine imaging and its relation with frontostriatal cognitive function in Parkinson's disease: PET studies with [11C]NNC 112 and [18F]FDOPA (2008) Psychiatry Res, 163, pp. 171-182
Weder, B.J., Leenders, K.L., Vontobel, P., Impaired somatosensory discrimination of shape in Parkinson's disease: association with caudate nucleus dopaminergic function (1999) Hum Brain Mapp, 8, pp. 1-12
Mariè, R.M., Barre, L., Dupuy, B., Relationships between striatal dopamine denervation and frontal executive tests in Parkinson's disease (1999) Neurosci Lett, 260, pp. 77-80
Rinne, J.O., Portin, R., Ruottinen, H., Cognitive impairment and the brain dopaminergic system in Parkinson disease: [18F]fluorodopa positron emission tomographic study (2000) Arch Neurol, 57, pp. 470-475
Jokinen, P., Bruck, A., Aalto, S., Impaired cognitive performance in Parkinson's disease is related to caudate dopaminergic hypofunction and hippocampal atrophy (2009) Parkinsonism Relat Disord, 15, pp. 88-93
Nobili, F., Campus, C., Arnaldi, D., Cognitive-nigrostriatal relationships in de novo, drug-naïve Parkinson's disease patients: a [I-123]FP-CIT study (2010) Mov Disord, 25, pp. 35-43
Holthoff, V.A., Vieregge, P., Kessler, J., Discordant twins with Parkinson's disease: positron emission tomography and early signs of impaired cognitive circuits (1994) Ann Neurol, 6, pp. 176-182
Emre, M., Aarsland, D., Brown, R., Clinical diagnostic criteria for dementia associated with Parkinson's disease (2007) Mov Disord, 22, pp. 1689-1707
Litvan, I., Goldman, J.G., Troster, A.I., Diagnostic criteria for mild cognitive impairment in Parkinson's disease: Movement Disorder Society Task Force Guidelines (2012) Mov Disord, 27, pp. 349-356
Booij, J., Hemelaar, T.G., Speelman, J.D., One-day protocol for imaging of the nigrostriatal dopaminergic pathway in Parkinson's disease by [123]FPCIT SPECT (1999) J Nucl Med, 40, pp. 753-761
Varrone, A., Pellecchia, M.T., Amboni, M., Imaging of dopaminergic dysfunction with 123I-FP-CIT SPECT in early-onset parkin disease (2004) Neurology, 63, pp. 2097-2103
Polito, C., Berti, V., Ramat, S., Interaction of caudate dopamine depletion and brain metabolic changes with cognitive dysfunction in early Parkinson's disease (2012) Neurobiol Aging, 33, pp. 20629-20639
Kehagia, A.A., Barker, R.A., Robbins, T.W., Neuropsychological and clinical heterogeneity of cognitive impairment and dementia in patients with Parkinson's disease (2010) Lancet Neurol, 9, pp. 1200-1213
Shen, L.H., Liao, M.H., Tseng, Y.C., Recent advances in imaging of dopaminergic neurons for evaluation of neuropsychiatric disorders (2012) J Biomed Biotechnol, 2012, p. 259349
Yamanaka, T., Ishii, F., Umemura, A., Temporary deterioration of executive function after subthalamic deep brain stimulation in Parkinson's disease (2012) Clin Neurol Neurosurg, 114, pp. 347-351
Paschali, A., Messinis, L., Kargiotis, O., SPECT neuroimaging and neuropsychological functions in different stages of Parkinson's disease (2010) Eur J Nucl Med Mol Imaging, 37, pp. 1128-1140
Brück, A., Portin, R., Lindell, A., Positron emission tomography shows that impaired frontal lobe functioning in Parkinson's disease is related to dopaminergic hypofunction in the caudate nucleus (2001) Neurosci Lett, 311, pp. 81-84
van Beilen, M., Portman, A.T., Kiers, H.A.L., Striatal FDOPA uptake and cognition in advanced non-demented Parkinson's disease: a clinical and FDOPA-PET study (2008) Parkinsonism Relat Disord, 14, pp. 224-228
Lozza, C., Baron, J.C., Eidelberg, D., Executive processes in Parkinson's disease: FDG-PET and network analysis (2004) Hum Brain Mapp, 22, pp. 236-245
Lebedev, A.V., Westman, E., Simmons, A., Large-scale resting state network correlates of cognitive impairment in Parkinson's disease and related dopaminergic deficits (2014) Front Syst Neurosci, 8, p. 45
Ekman, U., Eriksson, J., Forsgren, L., Functional brain activity and presynaptic dopamine uptake in patients with Parkinson's disease and mild cognitive impairment: a cross-sectional study (2012) Lancet Neurol, 11, pp. 679-687
Narayanan, N.S., Rodnitzky, R.L., Uc, E.Y., Prefrontal dopamine signaling and cognitive symptoms of Parkinson's Disease (2013) Rev Neurosci, 24, pp. 267-278
Christopher, L., Marras, C., Duff-Canning, S., Combined insular and striatal dopamine dysfunction are associated with executive deficits in Parkinson's disease with mild cognitive impairment (2014) Brain, 137, pp. 565-575
Petrou, M., Bohnen, N.I., Muller, M.L., Aβ-amyloid deposition in patients with Parkinson disease at risk for development of dementia (2012) Neurology, 79, pp. 1161-1167
Gomperts, S.N., Locascio, J.J., Rents, D., Amyloid is linked to cognitive decline in patients with Parkinson disease without dementia (2013) Neurology, 80, pp. 85-91
Cognitive performances and DAT imaging in early Parkinson's disease with mild cognitive impairment: a preliminary study
Antonini A, Vitale C, Barone P, Cilia R, Righini A, Bonuccelli U, Abbruzzese G, Ramat S, Petrone A, Quatrale R, Marconi R, Ceravolo R, Stefani A, Lopiano L, Zappia M, Capus L, Morgante L, Tamma F, Tinazzi M, Colosimo C, Guerra UP, Valzania F, Fagioli G, Distefano A, Bagnato A, Feggi L, Anna S, Maria Teresa Rosaria De Cr, Nobili F, Mazzuca N, Baldari S, Eleopra R, Bestetti A, Benti R, Varrone A, Volterrani D, Massa R, Stocchi F, Schillaci O, Dore F, Zibetti M, Castellano G, Battista SG, Giorgetti G * The relationship between cerebral vascular disease and parkinsonism: The VADO study(498 views) Parkinsonism Relat D (ISSN: 1353-8020, 1873-5126, 1873-5126electronic), 2012; 18(6): 775-780. Impact Factor:3.274 ViewExport to BibTeXExport to EndNote